TherapeuticsMD: Q4 Earnings Insights

 

TherapeuticsMD TXMD reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

TherapeuticsMD missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an estimate of $-0.08.

Revenue was down $3.90 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 4.67% drop in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.10 -0.11 -0.12 -0.10
EPS Actual -0.11 -0.11 -0.11 -0.15
Revenue Estimate 25.87M 22.11M 19.77M 21.89M
Revenue Actual 25.41M 23.00M 19.87M 22.58M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

TXMD Logo
TXMDTherapeuticsMD Inc
$1.16-1.69%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
23.57
Growth
42.85
Quality
Not Available
Value
59.42
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...